38
total announcements
FISCHER.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,975 Cr
P/E (TTM)
12.1
EPS (TTM)
₹2.34
52W Low
₹28.11
52W High
₹121.70
Dividend Yield
0.17%
Beta
0.18
Price / Book
4.7
Debt / Equity
27.7
Revenue (TTM)
₹367 Cr
Gross Margin
34.33%
Operating Margin
12.07%
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants. The company has allotted 4,54,210 Equity Shares at an issue price of Rs. 23.40/- (including a premium of Rs. 22.40 per share) upon exercising the option available with the Share Warrant Holder to convert warrants.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants. The company has allotted 2,05,05,909 (Two Crore Five Lakhs Five Thousand and Nine Hundred and Nine Only) Equity Shares at an issue price of Rs. 23.40/- (Rupees Twenty Three and Forty Paise Only) upon exercising the option available with the Share Warrant Holder.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has announced the resignation of two independent directors, Mr. Roberto M Pagdanganan and Mr. Sanjay Jayantilal Jain, due to personal reasons and pre-occupation with other professional commitments.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net loss of ₹350.41 lakhs. The company has also announced the resignation of two independent directors and the reconstitution of the audit and nomination and remuneration committees. Additionally, the company has allotted 2,05,05,909 equity shares to promoters and non-promoters on a preferential basis.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations, detailing the utilization of funds raised through a preferential issue of equity shares and fully convertible share warrants. The report indicates no deviation from the objects of the issue.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the allotment of equity shares pursuant to conversion of warrants. The company has allotted 1,42,78,217 equity shares at an issue price of Rs. 23.40 per share, aggregating to Rs. 25,05,82,708.35.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about allotment of equity shares pursuant to conversion of warrants.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the allotment of 23,00,000 (Twenty Three Lakhs) Equity Shares upon exercising the option available with the Share Warrant Holder to convert 23,00,000 (Twenty Three Lakhs) Convertible Warrants. The allotment has been made for cash at an issue price of Rs. 23.40/- (Rupees Twenty Three and Forty Paise Only) (including a premium of Rs. 22.40 per share) upon the receipt of the remaining exercise price of Rs. 17.55/- per warrant aggregating to Rs. 4,03,65,000/- (Rupees Four Crores Three Lakhs Sixty Five Thousand Only).
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about a newspaper advertisement regarding a special window for re-lodgement of transfer requests for physical shares.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has entered into a partnership with Parul Sevashram Hospital to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has received regulatory clearance from India's Central Licensing Authority (CDSCO) to import and distribute the Spincare Portable Wound Care System, a first-of-its-kind device in India's wound care market.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited replied to a clarification from the National Stock Exchange of India Limited regarding financial results for the quarter ended 31-Mar-2026. The company faced technical difficulties while accessing the NEAPS portal, which led to a delay in submitting the financial results. The company has taken measures to prevent such delays in the future.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance or rejection of securities for dematerialisation during the quarter ended 30/06/2026.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding the closure of the trading window for its promoters, directors, and designated persons due to the declaration of un-audited financial results for the quarter ended June 30, 2026.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has been asked by the Exchange to clarify its financial results for the quarter ended 31-Mar-2026 under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.